Clinical diagnosis of Alzheimer's disease
Клиническая диагностика болезни Альцгеймера
1984-07-01
SCID: 54.1/7fg883yr
Discuss with AI
Alzheimer's diseaseclinical criteriainsidious onsetneuropsychological testsprobable/possible/definite diagnosis
Figures from the paper
Abstract (AI)
Clinical criteria for the diagnosis of Alzheimer's disease include insidious onset and progressive impairment of memory and other cognitive functions. There are no motor, sensory, or coordination deficits early in the disease. The diagnosis cannot be determined by laboratory tests. These tests are important primarily in identifying other possible causes of dementia that must be excluded before the diagnosis of Alzheimer's disease may be made with confidence. Neuropsychological tests provide confirmatory evidence of the diagnosis of dementia and help to assess the course and response to therapy. The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information become available.
Key Findings
1
Clinical diagnosis of Alzheimer's disease relies on insidious onset and progressive impairment of memory and other cognitive functions.
2
Early Alzheimer's disease lacks motor, sensory, or coordination deficits.
3
Neuropsychological tests provide confirmatory evidence of dementia and help assess disease course and response to therapy.
4
No laboratory tests can determine the diagnosis of Alzheimer's disease; lab tests are primarily used to exclude other causes of dementia.
5
Proposed criteria classify cases as probable, possible, or definite Alzheimer's disease and will be revised as more information becomes available.
Research Object
Clinical diagnosis process for Alzheimer's disease
Research Subject
Diagnostic criteria and clinical features (insidious onset, progressive memory and cognitive impairment, absence of early motor/sensory/coordination deficits), role of laboratory and neuropsychological tests in distinguishing probable, possible, and definite Alzheimer's disease
Publication Details
Publication Date
1984-07-01
Journal
Publisher
ISSN
Cited by
27857
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by18
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment2005
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease2018
Mild Cognitive Impairment1999
Mild cognitive impairment as a diagnostic entity2004
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 20192022
Current Concepts in Mild Cognitive Impairment2001
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI2004
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease1998
Dynamics of Gray Matter Loss in Alzheimer's Disease2003
Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease2010
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases2018
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease2019
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study2018
Late-Life Depression, Mild Cognitive Impairment, and Dementia2012
A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer’s disease2021
Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach2015
Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by Toxoplasma gondii Infection2020